- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | LifeStance Health auf Morgan Stanley Konferenz: Wachstum und Margen im Fokus | - | Investing.com Deutsch | ||
| 11.09. | LifeStance Health Group, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 09.09. | LifeStance prices 22.3 million share secondary offering at $12.35 | 1 | Investing.com | ||
| 09.09. | LifeStance Health Group, Inc.: LifeStance Health Group Announces Pricing of Secondary Public Offering | 3 | GlobeNewswire (USA) | ||
| 09.09. | Canaccord raises Lifestance Health stock price target on growth outlook | 1 | Investing.com | ||
| LIFESTANCE HEALTH GROUP Aktie jetzt für 0€ handeln | |||||
| 09.09. | LifeStance stockholders plan to sell 22.3 million shares | 1 | Investing.com | ||
| 10.08. | LifeStance Health gains as Hedgeye adds as new long idea | 1 | Seeking Alpha | ||
| 06.08. | LifeStance Q2 2026 slides: 94% EBITDA surge, raised outlook | 9 | Investing.com | ||
| 06.08. | LifeStance Q2 2026 slides: profitability surges as margins expand | 1 | Investing.com | ||
| 06.08. | LifeStance Health Group beats top-line and bottom-line estimates; raises FY26 outlook | 2 | Seeking Alpha | ||
| 06.08. | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | 567 | GlobeNewswire (Europe) | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| 07.07. | LifeStance Health Group, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 05.06. | Goldman Sachs initiates Lifestance Health stock at neutral | 1 | Investing.com | ||
| 04.06. | LifeStance Health Group, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 26.05. | Bears are Losing Control Over LifeStance Health (LFST), Here's Why It's a 'Buy' Now | 5 | Zacks | ||
| 12.05. | LifeStance Health Group, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 08.05. | LifeStance Health Group prices secondary offering at $8.15 per share | 1 | Seeking Alpha | ||
| 08.05. | LifeStance Health prices secondary offering at $8.15 per share | 1 | Investing.com | ||
| 08.05. | LifeStance Health Group, Inc.: LifeStance Health Group Announces Pricing of Secondary Public Offering | 1 | GlobeNewswire (USA) | ||
| 07.05. | LifeStance: Aktionäre wollen 35 Millionen Aktien platzieren | 1 | Investing.com Deutsch |
1 2 Weiter >>
32 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 45,860 | -0,55 % | Vonovia sackt ab, Fresenius zieht an: DAX-Ausblick | Der DAX hat sich der abgelaufenen Woche weiter von seinem Rekordhoch entfernt. Unter dem Strich büßte das größte deutsche Börsenbarometer fast 500 Punkte ein und schloss -1,87% tiefer mit 25.559 Punkten.... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,680 | -0,82 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,150 | -0,70 % | BERENBERG stuft Siemens Healthineers auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat Siemens Healthineers mit einem Kursziel von 40 Euro auf "Hold" belassen. Der Medizintechnik- und Life-Science-Sektor bleibe fundamental attraktiv... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 29,660 | +2,21 % | BERENBERG stuft CARL ZEISS MEDITEC AG auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat Carl Zeiss Meditec mit einem Kursziel von 28 Euro auf "Hold" belassen. Der Medizintechnik- und Life-Science-Sektor bleibe fundamental attraktiv... ► Artikel lesen | |
| TELADOC HEALTH | 5,604 | +2,34 % | Teladoc Health, Inc.: Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors | NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 77,62 | +1,36 % | Eurofins: Director/PDMR Shareholding | Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each PDMR can be... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 37,805 | -0,37 % | Boston Scientific downgraded at Citi on increasing competition, cyberattack fallout | ||
| DEXCOM | 77,00 | +0,52 % | Dexcom's CFO Jereme Sylvain To Take Addl. Role Of COO | WASHINGTON (dpa-AFX) - DexCom Inc. (DXCM), a medical device company, announced the promotion of Jereme Sylvain to the role of Chief Operating Officer in addition to his duties as Chief Financial... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 130,95 | +0,34 % | Should You Continue to Hold ALGN Stock in Your Portfolio? | ||
| INMODE | 12,490 | -1,38 % | InMode slips as unsolicited takeover offer from M.N. Business Strategy expires | ||
| INVITAE | - | - | Patentstreit: Natera sichert sich 30 % Lizenzgebühr von Invitae | ||
| PETMED EXPRESS | 1,358 | -3,48 % | PetMed Express, Inc.: PetMeds Appoints Jeff Willard as CEO & President and Announces Board Leadership Transition | DELRAY BEACH, Fla., Sept. 17, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx (Nasdaq: PETS), today announced the appointment of consumer and e-commerce... ► Artikel lesen | |
| TANDEM DIABETES | 14,900 | -0,67 % | Tandem Diabetes Care, Inc.: Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets | Compatibility now available in five countries, with additional markets expected throughout 2026.Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company... ► Artikel lesen | |
| INSULET | 122,55 | -0,61 % | Insulet Corp. Q2 Profit Advances | WASHINGTON (dpa-AFX) - Insulet Corp. (PODD) released earnings for its second quarter that Increases, from the same period last yearThe company's earnings totaled $95.0 million, or $1.37 per... ► Artikel lesen | |
| MOLINA HEALTHCARE | 181,00 | +1,29 % | Cantor Fitzgerald bestätigt "Neutral"-Rating für Molina Healthcare |
Das Unternehmen LIFESTANCE HEALTH GROUP INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -0,12 % bei einem Aktienkurs von 12,595 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LIFESTANCE HEALTH GROUP INC finden Sie auf Wallstreet Online.